136 related articles for article (PubMed ID: 7801059)
1. Side effects of sulphasalazine in patients with rheumatic diseases or inflammatory bowel disease.
Laasila K; Leirisalo-Repo M
Scand J Rheumatol; 1994; 23(6):338-40. PubMed ID: 7801059
[TBL] [Abstract][Full Text] [Related]
2. Comparison of white blood cell dyscrasias during sulphasalazine therapy of rheumatoid arthritis and inflammatory bowel disease.
Capell HA; Pullar T; Hunter JA
Drugs; 1986; 32 Suppl 1():44-8. PubMed ID: 2877852
[TBL] [Abstract][Full Text] [Related]
3. [Sulfasalazine in rheumatology].
Nurchis P; Garau P; Pala MR; Uras L; Saviano M; Mathieu A
Ann Ital Med Int; 1990; 5(3 Pt 1):186-91. PubMed ID: 1981136
[TBL] [Abstract][Full Text] [Related]
4. Tofacitinib for the treatment of inflammatory bowel disease-associated arthritis: two case reports.
Momen Majumder MS; Haq SA; Rasker JJ
J Med Case Rep; 2023 Mar; 17(1):71. PubMed ID: 36855206
[TBL] [Abstract][Full Text] [Related]
5. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease.
Pearce CB; Duncan HD; Timmis L; Green JR
Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):439-43. PubMed ID: 10783998
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel disease.
Astbury C; Taggart AJ; Juby L; Zebouni L; Bird HA
Ann Rheum Dis; 1990 Aug; 49(8):587-90. PubMed ID: 1975737
[TBL] [Abstract][Full Text] [Related]
8. Histocompatibility antigens in inflammatory bowel disease. Their clinical significance and their association with arthropathy with special reference to HLA-B27 (W27).
Mallas EG; Mackintosh P; Asquith P; Cooke WT
Gut; 1976 Nov; 17(11):906-10. PubMed ID: 1001980
[TBL] [Abstract][Full Text] [Related]
9. Is Asacol as effective as sulphasalazine in maintaining remission of Crohn's disease and ulcerative colitis?
Nakshabendi IM; Duncan A; Russell RI
Postgrad Med J; 1992 Mar; 68(797):189-91. PubMed ID: 1350343
[TBL] [Abstract][Full Text] [Related]
10. [Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis].
Mundo A; Pedone V; Lamanna G; Cervini C
Clin Ter; 1997; 148(1-2):7-13. PubMed ID: 9377840
[TBL] [Abstract][Full Text] [Related]
11. Rheumatoid arthritis: a risk factor for sulphasalazine toxicity? A meta-analysis.
Wijnands MJ; Van 'T Hof MA; Van De Putte LB; Van Riel PL
Br J Rheumatol; 1993 Apr; 32(4):313-8. PubMed ID: 8096419
[TBL] [Abstract][Full Text] [Related]
12. Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazine.
el-Omar E; Penman I; Cruikshank G; Dover S; Banerjee S; Williams C; McColl KE
Gut; 1994 Oct; 35(10):1385-8. PubMed ID: 7959192
[TBL] [Abstract][Full Text] [Related]
13. Sulfasalazine: I. An historical perspective.
Bachrach WH
Am J Gastroenterol; 1988 May; 83(5):487-96. PubMed ID: 2896458
[No Abstract] [Full Text] [Related]
14. Sulfasalazine intolerance. A retrospective survey of the reasons for discontinuing treatment with sulfasalazine in patients with chronic inflammatory bowel disease.
Nielsen OH
Scand J Gastroenterol; 1982 Apr; 17(3):389-93. PubMed ID: 6127793
[TBL] [Abstract][Full Text] [Related]
15. [Aminosalicylates in chronic inflammatory intestinal diseases and rheumatoid arthritis].
Maier KP
Dtsch Med Wochenschr; 1992 Oct; 117(42):1614-5. PubMed ID: 1356747
[No Abstract] [Full Text] [Related]
16. Current status of drug therapy for inflammatory bowel disease.
Peppercorn MA
Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
[TBL] [Abstract][Full Text] [Related]
17. Incidence of sulphasalazine-induced male infertility.
Birnie GG; McLeod TI; Watkinson G
Gut; 1981 Jun; 22(6):452-5. PubMed ID: 6114898
[TBL] [Abstract][Full Text] [Related]
18. Sulphasalazine and spermatogenesis.
Freeman JG; Reece VA; Venables CW
Digestion; 1982; 23(1):68-71. PubMed ID: 6123457
[TBL] [Abstract][Full Text] [Related]
19. The value of 5-aminosalicylic acid in inflammatory bowel disease for patients intolerant or allergic to sulphasalazine.
Donald IP; Wilkinson SP
Postgrad Med J; 1985 Dec; 61(722):1047-8. PubMed ID: 2869480
[TBL] [Abstract][Full Text] [Related]
20. Ankylosing spondylitis and inflammatory bowel disease. III. Clinical characteristics and results of histocompatibility typing (HLA B27) in 50 patients with both ankylosing spondylitis and inflammatory bowel disease.
Dekker-Saeys BJ; Meuwissen SG; Van Den Berg-Loonen EM; De Haas WH; Meijers KA; Tytgat GN
Ann Rheum Dis; 1978 Feb; 37(1):36-41. PubMed ID: 629602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
